// App-Quantinova.ai

: Targeting Protease Nexin‐1, a Natural Anticoagulant, to Control Bleeding in Hemophilia A

Researchers

Presenter

  • K. Aymonnier

Principal Investigators

  • C. Kawecki

  • L. Venisse

  • E. De Raucourt

  • O. Christophe

  • P. Lenting

  • V. Arocas

  • C. Denis

  • M.-C. Bouton

Medical Centers

  • INSERM, Paris, France

  • INSERM U693, Le Kremlin Bicetre, France

  • Hôpital Beaujon, Service Hématologie Biologique, Clichy, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • Catalase

Drug/Treatment

  • Evithrom

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved